IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients

被引：18
|
作者：
Dierckx, T. [1 ]
Khouri, R. [1 ,2 ]
Menezes, S. M. [1 ]
Decanine, D. [2 ]
Farre, L. [2 ]
Bittencourt, A. [3 ]
Vandamme, A. M. [1 ,4 ]
Van Weyenbergh, J. [1 ,2 ]
机构：
[1] Univ Leuven, KU Leuven, Rega Inst Med Res, Dept Microbiol & Immunol,Lab Clin & Epidemol Viro, Leuven, Belgium
[2] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil
[3] Univ Fed Bahia, Hosp Univ Prof Edgar Santos, Salvador, BA, Brazil
[4] Univ Nova Lisboa, Ctr Global Hlth & Trop Med, Inst Higiene & Med Trop, Unidade Microbiol, Lisbon, Portugal
来源：
BLOOD CANCER JOURNAL | 2017年 / 7卷
关键词：
LEUKEMIA-LYMPHOMA; INTERFERON-ALPHA; HTLV-I; ZIDOVUDINE; EXPRESSION; LINES;
D O I：
10.1038/bcj.2016.126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e519 / e519
页数：4
相关论文
共 20 条
  • [1] IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients
    T Dierckx
    R Khouri
    S M Menezes
    D Decanine
    L Farre
    A Bittencourt
    A M Vandamme
    J Van Weyenbergh
    Blood Cancer Journal, 2017, 7 : e519 - e519
  • [2] Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells
    Kinpara, Shuichi
    Kijiyama, Mami
    Takamori, Ayako
    Hasegawa, Atsuhiko
    Sasada, Amane
    Masuda, Takao
    Tanaka, Yuetsu
    Utsunomiya, Atae
    Kannagi, Mari
    RETROVIROLOGY, 2013, 10
  • [3] Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells
    Shuichi Kinpara
    Mami Kijiyama
    Ayako Takamori
    Atsuhiko Hasegawa
    Amane Sasada
    Takao Masuda
    Yuetsu Tanaka
    Atae Utsunomiya
    Mari Kannagi
    Retrovirology, 10
  • [4] Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma
    Tawara, M
    Hogerzeil, SJ
    Yamada, Y
    Takasaki, Y
    Soda, H
    Hasegawa, H
    Murata, K
    Ikeda, S
    Imaizumi, Y
    Sugahara, K
    Tsuruda, K
    Tsukasaki, K
    Tomonaga, M
    Hirakata, Y
    Kamihira, S
    CANCER LETTERS, 2006, 234 (02) : 249 - 255
  • [5] GENETIC ALTERATION OF P53 IN SOME PATIENTS WITH ADULT T-CELL LEUKEMIA
    NAGAI, H
    KINOSHITA, T
    IMAMURA, J
    MURAKAMI, Y
    HAYASHI, K
    MUKAI, K
    IKEDA, S
    TOBINAI, K
    SAITO, H
    SHIMOYAMA, M
    SHIMOTOHNO, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (12): : 1421 - 1427
  • [6] P53/p16 analysis in Brazilian adult t-cell leukemia patients
    de Oliveira, MP
    Cavalcanti, G
    Fernandes, MA
    Klumb, CE
    Maia, RC
    Dobbin, J
    Rios, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 392 - 392
  • [7] P53 deletions/mutations in Brazilian adult T-cell leukemia patients.
    Pombo-de-Oliveira, MS
    Zhu, SW
    Carrico, MK
    Bianco, C
    Rios, M
    BLOOD, 2000, 96 (11) : 229B - 229B
  • [8] Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-α-refractory adult T-cell leukemia
    Mone, A
    Puhalla, S
    Whitman, S
    Baiocchi, RA
    Cruz, J
    Vukosavljevic, T
    Banks, A
    Eisenbeis, CF
    Byrd, JC
    Caligiuri, MA
    Porcu, P
    BLOOD, 2005, 106 (10) : 3380 - 3382
  • [9] P53 GENE MUTATION AND LOSS OF HETEROZYGOSITY ARE ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION IN ADULT T-CELL LEUKEMIA
    NISHIMURA, S
    ASOU, N
    SUZUSHIMA, H
    OKUBO, T
    FUJIMOTO, T
    OSATO, M
    YAMASAKI, H
    LISHA, L
    TAKATSUKI, K
    LEUKEMIA, 1995, 9 (04) : 598 - 604
  • [10] Ribavirin and IFN-α combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B
    Fen-Yu Ren
    World Journal of Gastroenterology, 2007, (41) : 5440 - 5445
12